chen zhao
chen zhao
The University of Texas MD Anderson Cancer Center
Email verificata su mdanderson.org
TitoloCitata daAnno
Alteration in copy numbers of genes as a mechanism for acquired drug resistance
K Yasui, S Mihara, C Zhao, H Okamoto, F Saito-Ohara, A Tomida, ...
Cancer research 64 (4), 1403-1410, 2004
2262004
TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas
K Yasui, S Arii, C Zhao, I Imoto, M Ueda, H Nagai, M Emi, J Inazawa
Hepatology 35 (6), 1476-1484, 2002
1682002
Elevated expression levels of NCOA3, TOP1, and TFAP2C in breast tumors as predictors of poor prognosis
C Zhao, K Yasui, CJ Lee, H Kurioka, Y Hosokawa, T Oka, J Inazawa
Cancer 98 (1), 18-23, 2003
1062003
PTK2 and EIF3S3 genes may be amplification targets at 8q23‐q24 and are associated with large hepatocellular carcinomas
H Okamoto, K Yasui, C Zhao, S Arii, J Inazawa
Hepatology 38 (5), 1242-1249, 2003
1042003
Aurora kinase B is a predictive factor for the aggressive recurrence of hepatocellular carcinoma after curative hepatectomy
S Tanaka, S Arii, M Yasen, K Mogushi, NT Su, C Zhao, I Imoto, Y Eishi, ...
British Journal of Surgery 95 (5), 611-619, 2008
922008
POU2AF1, an amplification target at 11q23, promotes growth of multiple myeloma cells by directly regulating expression of a B-cell maturation factor, TNFRSF17
C Zhao, J Inoue, I Imoto, T Otsuki, S Iida, R Ueda, J Inazawa
Oncogene 27 (1), 63-75, 2007
302007
Pathway Bridge Based Multiobjective Optimization Approach for Lurking Pathway Prediction
XZ Rengjing Zhang, Chen Zhao, Zixiang Xiong
Biomed Res Int 2014, 2014
52014
Method for detecting multiple myeloma and method for inhibiting the same
C Zhao, J Inoue, I Imoto, J Inazawa
US Patent App. 11/902,504, 2007
12007
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–8